Celularity (CELUW) Equity Ratio (2018 - 2025)

Celularity (CELUW) reported Equity Ratio of 0.35 for Q4 2025, down 632.45% year-over-year from 0.07 in Q4 2024, and down 101.61% quarter-over-quarter from 0.18 in Q3 2025.

Celularity (CELUW) Equity Ratio (2018 - 2025) Analysis & Trends

Celularity (CELUW) has 8 years of Equity Ratio data on file, last reported at 0.35 in Q4 2025.

  • Equity Ratio for Q4 2025 came in at 0.35, down 632.45% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.35 (down 632.45% YoY), and the FY2025 annual result was 0.35, down 632.45% from the prior year.
  • Equity Ratio fell to 0.35 in Q4 2025 per CELUW's latest filing, from 0.18 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.5 in Q4 2022 and troughed at 5.05 in Q2 2021.
  • A 5-year average of 0.2 and a median of 0.21 in 2022 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2021 and 2025: Equity Ratio soared 119.47% in 2021, then tumbled 632.45% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.24 in 2021, then jumped by 106.58% to 0.5 in 2022, then tumbled by 42.6% to 0.28 in 2023, then plunged by 76.6% to 0.07 in 2024, then tumbled by 632.45% to 0.35 in 2025.
  • Business Quant data shows CELUW's Equity Ratio at 0.35 in Q4 2025, 0.18 in Q3 2025, and 0.21 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 191.07
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 0.98
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 0.04
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.42
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.73
9 Abivax 91.96 Bn 91.96 Bn - 0.79
10 Celularity - - -3.27 Mn -0.35

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.35
Sep 30, 2025 -0.18
Jun 30, 2025 -0.21
Mar 31, 2025 -0.04
Dec 31, 2024 0.07
Sep 30, 2024 0.13
Jun 30, 2024 0.21
Mar 31, 2024 0.22
Dec 31, 2023 0.28
Sep 30, 2023 0.19
Jun 30, 2023 0.48
Mar 31, 2023 0.43
Dec 31, 2022 0.50
Sep 30, 2022 0.38
Jun 30, 2022 0.35
Mar 31, 2022 0.21
Dec 31, 2021 0.24
Sep 30, 2021 0.21
Jun 30, 2021 -5.05
Mar 31, 2021 -2.10